Brusatol may serve as potential adjuvant therapy for pancreatic ductal adenocarcinoma

Announcing a new publication for Acta Materia Medica journal. Chemoresistance to gemcitabine (Gem) remains a substantial obstacle in the treatment of pancreatic ductal adenocarcinoma carcinoma (PDAC).

New European research and innovation project launched to study healthy aging

A new European research and innovation project studying healthy ageing launched this month. This collaborative project has been awarded funding from Horizon Europe, the EU’s

January 24, 2024

Yale Law School’s free speech group says Boehringer’s IRA argument is ‘fundamentally flawed’

Yale Law School’s Floyd Abrams Institute for Freedom of Expression described Boehringer Ingelheim’s First Amendment arguments in its Inflation Reduction Act lawsuit as “extraordinarily troubling.” Boehringer filed

January 3, 2024

Dollar General pulls mobile clinic mentions from website, partner no longer offering appointments

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

May 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.